NIH-funded research R01 grant

Investigating the effects of phthalate exposure on premature infants in the NICU

Official title: Phthalate Exposure and Mechanisms of Action in the Neonatal Intensive Care Unit

Funded at Feinstein Institute for Medical Research · NIH-10736301 · Data updated 2026-11-12

This study is looking at how certain chemicals found in hospitals might affect the health and development of premature babies in NICUs, with the hope of finding ways to keep these little ones safer and healthier.

More Intensive Care research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionFeinstein Institute for Medical Research
NIH-funded
Lab location1 site (Manhasset, United States)
Project startSeptember 1, 2023
Project endAugust 31, 2026
Funding year2023
Award (this year)$1,999,075
NIH project number1R01ES034018-01A1
Project IDNIH-10736301 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are premature infants admitted to neonatal intensive care units.

Less likely to help

Patients who are not premature or who are not admitted to a NICU may not benefit from this research.

What this research studies

This research focuses on understanding how exposure to phthalates, common chemicals found in hospital environments, affects premature infants in neonatal intensive care units (NICUs). The study aims to identify the sources of phthalate exposure and its potential impact on neurodevelopment, growth, and lung health in these vulnerable infants. By analyzing data from NICU patients, researchers will explore the mechanisms through which phthalates may influence health outcomes. The goal is to improve care practices and reduce harmful exposures for infants receiving critical care.

Why it matters

Potential benefit: If successful, this research could lead to improved health outcomes for premature infants by minimizing harmful chemical exposures in NICUs.

How similar studies have gone: Previous research has indicated that phthalate exposure can adversely affect health outcomes in infants, suggesting that this investigation builds on established findings.

Where this research is happening

  • Feinstein Institute for Medical Research
    Manhasset, United States
    Active

Researchers

  • Principal investigator: Stroustrup, Annemarie — Feinstein Institute for Medical Research
  • Study coordinator: Stroustrup, Annemarie

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.